Topic Archives: Sanofi (SNY)

Alzheimer’s Disease is on everyone’s mind these days, thanks to Biogen’s (BIIB) controversial FDA approval for marketing Aduhelm as the first Alzheimer’s treatment in years, and arguably the first disease-modifying treatment at all… so both hope (for patients and families) and greed (for investors) are back in the picture. The dispute over the approval was […]

“I firmly believe that if the whole materia medica could be sunk to the bottom of the sea, it would be all the better for mankind and all the worse for the fishes.”  — Oliver Wendell Holmes, M. D., Professor of Medicine , Harvard “With all his conscience and one eye askew, So false he […]

[ed note: Dr. KSS is a paid contributor to Stock Gumshoe who writes about biotech stocks for (and discusses them with) the Irregulars. He chooses his own topics, and his words and opinions are his alone. Enjoy!] Greetings fellow Irregulars!  You’ve all been waiting for it….our first-ever annual ceremony in which we look back on […]

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Any discussion of cholesterol immediately turns Brobdingnagian, such are the extremes in question. Statins, which lower LDL cholesterol, are bombastically the best-selling drugs of all […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]

Comments

  • $TSRO $GILD $SNY "Buyout Buzz: Sanofi, Gilead rumors keep the fire burning under a boiling Tesaro buyout story" At...

  • this was a $2.00 stock at the time of the original post above (9 months ago). WOW Flexion Therapeutics - $FLXN +40% j...

  • Pre-market actions, 1/6, per IBD at 8:45am In Motion: Amgen, Regeneron, Ionis, Verizon Premarket action was a mixe...

  • Sanofi (SNY) and Google teaming up for new start up Onduo targeting diabetes treatments. http://www.xconomy.com/bosto...

  • Long $RLYP http://tinyurl.com/j5bmn49 Short article, and nice summation of current position. RLYP has applied for Eu...

  • I think Sanofi ($SNY) was meant....

  • Sanofi (SNY) on the hunt for rare disease acquisitions. http://finance.yahoo.com/news/100-billion-french-pharma-giant...

  • Doc KSS, First and foremost, glad you are on the mend. I was wondering if you could kindly comment on the effica...

  • Could be, the hints were all over the map on this since he's teasing RNAi generally and hinting at lots of studies done ...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info